Drug Profile
Lamotrigine/sertraline
Alternative Names: 15/30-SER-LAM; 30/15-LAM/SER; LAM/SER; SER/LAM; Sertraline/lamotrigineLatest Information Update: 05 Sep 2017
Price :
$50
*
At a glance
- Originator Meditop Pharmaceutical
- Class Amines; Analgesics; Naphthalenes; Small molecules; Triazines
- Mechanism of Action Serotonin uptake inhibitors; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Back pain
Most Recent Events
- 16 Dec 2014 Meditop Pharmaceutical completes a phase II trial in Back pain in Hungary (EudraCT2013-004564-55)
- 12 Jun 2014 Phase-II clinical trials in Back pain in Romania (PO) (EudraCT2013-004564-55)
- 10 Mar 2014 Phase-II clinical trials in Back pain in Hungary (PO)